BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hu X, Zhu H, Chen B, He X, Shen Y, Zhang X, Chen W, Liu X, Xu Y, Xu X. Tubulin Alpha 1b Is Associated with the Immune Cell Infiltration and the Response of HCC Patients to Immunotherapy. Diagnostics 2022;12:858. [DOI: 10.3390/diagnostics12040858] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhu H, Hu X, Feng S, Li Y, Zhang Y, Qiu S, Chen R, Ye Y, Gu L, Jian Z, Xu X, Xiong X. APOL4, a Novel Immune-Related Prognostic Biomarker for Glioma. JCM 2022;11:5765. [DOI: 10.3390/jcm11195765] [Reference Citation Analysis]
2 Hu X, Zhu H, Feng S, Wang C, Ye Y, Xiong X. Transmembrane and coiled-coil domains 3 is a diagnostic biomarker for predicting immune checkpoint blockade efficacy in hepatocellular carcinoma. Front Genet 2022;13:1006357. [DOI: 10.3389/fgene.2022.1006357] [Reference Citation Analysis]
3 Alhammad R. Bioinformatics Identification of TUBB as Potential Prognostic Biomarker for Worse Prognosis in ERα-Positive and Better Prognosis in ERα-Negative Breast Cancer. Diagnostics 2022;12:2067. [DOI: 10.3390/diagnostics12092067] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Zhu H, Hu X, Feng S, Gu L, Jian Z, Zou N, Xiong X. Predictive value of PIMREG in the prognosis and response to immune checkpoint blockade of glioma patients. Front Immunol 2022;13:946692. [DOI: 10.3389/fimmu.2022.946692] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]